Q4 2024 · 13F-HR
DIADEMA PARTNERS LPholdings as filed
Filed 2025-02-14 · accession 0001892688-25-000086
$233.1M
Reported value
107
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $23.1M | 9.92% | 57,400 | CALL | SOLE |
| 78464A870 | XBI | SPDR SER TR | $18.0M | 7.73% | 200,000 | PUT | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $9.0M | 3.88% | 160,000 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $8.9M | 3.81% | 50,000 | PUT | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $8.9M | 3.81% | 50,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $7.9M | 3.38% | 175,400 | PUT | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $7.7M | 3.29% | 100,000 | PUT | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $7.5M | 3.22% | 190,800 | CALL | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $6.7M | 2.86% | 300,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $6.0M | 2.58% | 200,000 | PUT | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $5.6M | 2.40% | 64,193 | Common | SOLE |
| 40637H109 | HALO | HALOZYME THERAPEUTICS INC | $4.8M | 2.05% | 100,000 | CALL | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.4M | 1.90% | 105,500 | PUT | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $4.3M | 1.82% | 94,600 | CALL | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $4.2M | 1.80% | 75,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $3.9M | 1.69% | 30,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $3.9M | 1.67% | 56,337 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $3.7M | 1.60% | 100,000 | CALL | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $3.6M | 1.57% | 43,700 | CALL | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $3.5M | 1.49% | 25,276 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $3.5M | 1.48% | 50,000 | CALL | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $3.4M | 1.44% | 102,000 | CALL | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $3.3M | 1.43% | 60,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.2M | 1.39% | 71,988 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $3.2M | 1.37% | 100,000 | CALL | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $2.8M | 1.22% | 215,000 | CALL | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $2.8M | 1.18% | 200,000 | CALL | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $2.7M | 1.18% | 100,000 | CALL | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $2.5M | 1.08% | 100,000 | CALL | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $2.5M | 1.06% | 165,965 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $2.3M | 0.99% | 53,160 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $2.3M | 0.98% | 50,620 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.2M | 0.95% | 131,862 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $2.2M | 0.94% | 52,300 | CALL | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $2.1M | 0.89% | 505,778 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $2.1M | 0.88% | 130,000 | CALL | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $2.0M | 0.87% | 300,000 | CALL | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $1.9M | 0.80% | 43,000 | CALL | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $1.8M | 0.78% | 14,719 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.8M | 0.76% | 100,000 | CALL | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $1.7M | 0.74% | 214,291 | Common | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $1.4M | 0.62% | 200,000 | CALL | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $1.4M | 0.62% | 47,805 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $1.4M | 0.59% | 114,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $1.3M | 0.57% | 25,900 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $1.3M | 0.57% | 100,000 | PUT | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $1.3M | 0.56% | 442,520 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $1.2M | 0.52% | 60,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $1.2M | 0.49% | 14,701 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $1.1M | 0.46% | 97,423 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $1.0M | 0.43% | 63,547 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $999,000 | 0.43% | 8,767 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $948,493 | 0.41% | 49,478 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $942,000 | 0.40% | 100,000 | CALL | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $936,950 | 0.40% | 17,500 | PUT | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $888,160 | 0.38% | 104,000 | CALL | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $876,268 | 0.38% | 371,300 | PUT | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $860,720 | 0.37% | 81,200 | CALL | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $818,600 | 0.35% | 10,000 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $810,060 | 0.35% | 58,700 | PUT | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $797,832 | 0.34% | 50,400 | PUT | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $774,569 | 0.33% | 10,100 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $740,000 | 0.32% | 100,000 | CALL | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $734,000 | 0.31% | 100,000 | CALL | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $710,514 | 0.30% | 101,502 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $708,000 | 0.30% | 200,000 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $702,000 | 0.30% | 90,000 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $673,961 | 0.29% | 374,423 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $649,995 | 0.28% | 698,919 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $532,500 | 0.23% | 50,000 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $507,740 | 0.22% | 191,600 | PUT | SOLE |
| 014442107 | ALEC | ALECTOR INC | $451,746 | 0.19% | 239,019 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $422,026 | 0.18% | 679 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $421,725 | 0.18% | 30,000 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $418,761 | 0.18% | 158,023 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $412,000 | 0.18% | 100,000 | CALL | SOLE |
| 29479A108 | ERAS | ERASCA INC | $394,002 | 0.17% | 156,973 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $356,900 | 0.15% | 20,000 | CALL | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $350,956 | 0.15% | 42,081 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $330,126 | 0.14% | 197,680 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $312,271 | 0.13% | 75,794 | Common | SOLE |
| 27900N103 | WAVE | ECO WAVE POWER GLOBAL AB | $291,932 | 0.13% | 23,600 | CALL | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $288,360 | 0.12% | 80,100 | CALL | SOLE |
| 137404109 | CADL | CANDEL THERAPEUTICS INC | $285,572 | 0.12% | 32,900 | PUT | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $279,050 | 0.12% | 50,370 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $277,032 | 0.12% | 71,400 | PUT | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $232,392 | 0.10% | 256,900 | CALL | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $197,191 | 0.08% | 217,987 | Common | SOLE |
| 137404109 | CADL | CANDEL THERAPEUTICS INC | $173,600 | 0.07% | 20,000 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $151,683 | 0.07% | 8,500 | PUT | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $120,744 | 0.05% | 35,100 | PUT | SOLE |
| 78397T202 | SABS | SAB BIOTHERAPEUTICS INC | $113,826 | 0.05% | 30,000 | Common | SOLE |
| 16934W106 | CMRXEUR | CHIMERIX INC | $101,205 | 0.04% | 29,082 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $72,635 | 0.03% | 7,300 | CALL | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $67,768 | 0.03% | 19,700 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $65,403 | 0.03% | 16,900 | PUT | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $64,963 | 0.03% | 38,900 | CALL | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $44,091 | 0.02% | 2,300 | PUT | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $36,285 | 0.02% | 1,359 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $33,760 | 0.01% | 3,200 | CALL | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $32,782 | 0.01% | 4,710 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $20,454 | 0.01% | 21,508 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $19,264 | 0.01% | 5,600 | CALL | SOLE |
| 03835L405 | — | APTEVO THERAPEUTICS INC | $17,456 | 0.01% | 4,050 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $14,706 | 0.01% | 3,800 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $591 | 0.00% | 800 | CALL | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $590 | 0.00% | 200 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.